{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:01:46Z","timestamp":1781715706643,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Environ Biophys"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00411-022-00967-5","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:03:08Z","timestamp":1648155788000},"page":"205-219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Amelioration of cognitive and biochemical impairment in A\u03b2-based rodent model of Alzheimer\u2019s disease following fractionated X-irradiation"],"prefix":"10.1007","volume":"61","author":[{"given":"Anna","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Sati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozy","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devinder K.","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-477X","authenticated-orcid":false,"given":"Vijayta D.","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"967_CR1","doi-asserted-by":"publisher","DOI":"10.2174\/157015911798376235","author":"K Alkadhi","year":"2011","unstructured":"Alkadhi K, Eriksen J (2011) The complex and multifactorial nature of Alzheimer\u2019s disease. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/157015911798376235","journal-title":"Curr Neuropharmacol"},{"key":"967_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310202","author":"MF Beal","year":"1992","unstructured":"Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol. https:\/\/doi.org\/10.1002\/ana.410310202","journal-title":"Ann Neurol"},{"key":"967_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2007.04.381","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1016\/j.jalz.2007.04.381","journal-title":"Alzheimer\u2019s Dement"},{"key":"967_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3892\/mmr.2014.2040","volume":"9","author":"Z Cai","year":"2014","unstructured":"Cai Z (2014) Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer\u2019s disease (Review). Mol Med Rep 9:1533\u20131541","journal-title":"Mol Med Rep"},{"key":"967_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(85)13062-4","author":"I Carlberg","year":"1985","unstructured":"Carlberg I, Mannervik B (1985) [59] Glutathione reductase. Methods Enzymol. https:\/\/doi.org\/10.1016\/S0076-6879(85)13062-4","journal-title":"Methods Enzymol"},{"key":"967_CR6","doi-asserted-by":"crossref","unstructured":"Christen Y (2000) Oxidative stress and Alzheimer disease. In: American Journal of Clinical Nutrition","DOI":"10.1093\/ajcn\/71.2.621s"},{"key":"967_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2007.10.009","author":"R Christensen","year":"2008","unstructured":"Christensen R, Marcussen AB, W\u00f6rtwein G et al (2008) A\u03b2(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2007.10.009","journal-title":"Exp Neurol"},{"key":"967_CR8","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1111\/j.1471-4159.1973.tb00294.x","volume":"20","author":"RH Cox Jr","year":"1973","unstructured":"Cox RH Jr, Perhach JL Jr (1973) A sensitive, rapid, and simple method for the stimultaneous spectrophotofluorometric determinations of norepinephrine, dopamine, 5-hydroxytryptamine and 5-hydroxy-indoleacetic acid in discrete areas of brain. J Neurochem 20:1777\u20131780","journal-title":"J Neurochem"},{"key":"967_CR9","doi-asserted-by":"publisher","unstructured":"Driver AS, Kodavanti PRS, Mundy WR (2000) Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol. https:\/\/doi.org\/10.1016\/S0892-0362(99)00069-0","DOI":"10.1016\/S0892-0362(99)00069-0"},{"key":"967_CR10","first-page":"498","volume":"60","author":"J Drozak","year":"2006","unstructured":"Drozak J, Koz\u0142owski M (2006) Monoamine oxidase as a target for drug action. Postepy Hig Med Dosw (online) 60:498\u2013515","journal-title":"Postepy Hig Med Dosw (online)"},{"key":"967_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(59)90090-6","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys. https:\/\/doi.org\/10.1016\/0003-9861(59)90090-6","journal-title":"Arch Biochem Biophys"},{"key":"967_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(61)90145-9","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"key":"967_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.06.015","author":"J Espa\u00f1a","year":"2010","unstructured":"Espa\u00f1a J, Gim\u00e9nez-Llort L, Valero J et al (2010) Intraneuronal \u03b2-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer\u2019s disease transgenic mice. Biol Psychiatry. https:\/\/doi.org\/10.1016\/j.biopsych.2009.06.015","journal-title":"Biol Psychiatry"},{"key":"967_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/472932","author":"Y Feng","year":"2012","unstructured":"Feng Y, Wang X (2012) Antioxidant therapies for Alzheimer\u2019s disease. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2012\/472932","journal-title":"Oxid Med Cell Longev"},{"key":"967_CR15","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0482-13.2013","author":"CP Figueiredo","year":"2013","unstructured":"Figueiredo CP, Clarke JR, Ledo JH et al (2013) Memantine rescues transient cognitive impairment caused by high-molecular-weight A\u03b2 oligomers but not the persistent impairment induced by low-molecular-weight oligomers. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.0482-13.2013","journal-title":"J Neurosci"},{"key":"967_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1997.tb06815.x","author":"R Frussa-Filho","year":"1997","unstructured":"Frussa-Filho R, Ab\u00edlio VC, Bergamo M, Palermo-Neto J (1997) Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats. J Pharm Pharmacol. https:\/\/doi.org\/10.1111\/j.2042-7158.1997.tb06815.x","journal-title":"J Pharm Pharmacol"},{"key":"967_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/10715760802277388","author":"J Gunasingh Masilamoni","year":"2008","unstructured":"Gunasingh Masilamoni J, Philip Jesudason E, Dhandayuthapani S et al (2008) The neuroprotective role of melatonin against amyloid \u03b2 peptide injected mice. Free Radic Res. https:\/\/doi.org\/10.1080\/10715760802277388","journal-title":"Free Radic Res"},{"key":"967_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)42083-8","author":"WH Habig","year":"1974","unstructured":"Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S transferases The first enzymatic step in mercapturic acid formation. J Biol Chem. https:\/\/doi.org\/10.1016\/S0021-9258(19)42083-8","journal-title":"J Biol Chem"},{"key":"967_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"967_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(97)00091-0","author":"T Harkany","year":"1998","unstructured":"Harkany T, O\u2019Mahony S, Kelly JP et al (1998) \u03b2-Amyloid(Phe(SO3H)24)25\u201335 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behav Brain Res. https:\/\/doi.org\/10.1016\/S0166-4328(97)00091-0","journal-title":"Behav Brain Res"},{"key":"967_CR21","first-page":"559","volume":"41","author":"B Highman","year":"1946","unstructured":"Highman B (1946) Improved methods for demonstrating Amyloid in paraffin sections. Arch Path 41:559\u2013562","journal-title":"Arch Path"},{"key":"967_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23126","author":"T Hochstrasser","year":"2013","unstructured":"Hochstrasser T, Hohsfield LA, Sperner-Unterweger B, Humpel C (2013) \u03b2-Amyloid induced effects on cholinergic, serotonergic, and dopaminergic neurons is differentially counteracted by anti-inflammatory drugs. J Neurosci Res. https:\/\/doi.org\/10.1002\/jnr.23126","journal-title":"J Neurosci Res"},{"key":"967_CR23","doi-asserted-by":"publisher","DOI":"10.2174\/156720110793566245","author":"S Hossain","year":"2010","unstructured":"Hossain S, Akaike T, Hoque Chowdhury E (2010) Current approaches for drug delivery to central nervous system. Curr Drug Deliv. https:\/\/doi.org\/10.2174\/156720110793566245","journal-title":"Curr Drug Deliv"},{"key":"967_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2017.1312805","author":"C Hu","year":"2017","unstructured":"Hu C, Wang P, Zhang S et al (2017) Neuroprotective effect of melatonin on soluble A\u03b21\u201342-induced cortical neurodegeneration via Reelin\u2013Dab1 signaling pathway. Neurol Res. https:\/\/doi.org\/10.1080\/01616412.2017.1312805","journal-title":"Neurol Res"},{"key":"967_CR25","doi-asserted-by":"publisher","DOI":"10.5962\/bhl.title.5890","volume-title":"Animal tissue techniques","author":"GL Humanson","year":"1962","unstructured":"Humanson GL (1962) Animal tissue techniques. WH Freeman, San Francisco"},{"key":"967_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90125-A","author":"J Itoh","year":"1991","unstructured":"Itoh J, Nabeshima T, Kameyama T (1991) Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/0014-2999(91)90125-A","journal-title":"Eur J Pharmacol"},{"key":"967_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2006.09.100","author":"S Jana","year":"2007","unstructured":"Jana S, Maiti AK, Bagh MB et al (2007) Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson\u2019s disease. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2006.09.100","journal-title":"Brain Res"},{"key":"967_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Reddy PH (2017) Therapeutics of Neurotransmitters in Alzheimer\u2019s Disease. J Alzheimers Dis 57:1049\u20131069","journal-title":"J Alzheimers Dis"},{"key":"967_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(02)00401-1","author":"V Klenerov\u00e1","year":"2003","unstructured":"Klenerov\u00e1 V, Jur\u010dovi\u010dov\u00e1 J, Kaminsk\u00fd O et al (2003) Combined restraint and cold stress in rats: effects on memory processing in passive avoidance task and on plasma levels of ACTH and corticosterone. Behav Brain Res. https:\/\/doi.org\/10.1016\/S0166-4328(02)00401-1","journal-title":"Behav Brain Res"},{"key":"967_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(78)90479-4","author":"Y Kono","year":"1978","unstructured":"Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. https:\/\/doi.org\/10.1016\/0003-9861(78)90479-4","journal-title":"Arch Biochem Biophys"},{"key":"967_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.02.007","author":"GM Leggio","year":"2016","unstructured":"Leggio GM, Catania MV, Puzzo D et al (2016) The antineoplastic drug flavopiridol reverses memory impairment induced by amyloid-\u00df1-42 oligomers in mice. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2016.02.007","journal-title":"Pharmacol Res"},{"key":"967_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/BF00177912","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. https:\/\/doi.org\/10.1007\/BF00177912","journal-title":"Psychopharmacology"},{"issue":"1","key":"967_CR33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O Lowry","year":"1951","unstructured":"Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem\u00a0193(1):256\u2013275","journal-title":"J Biol Chem"},{"key":"967_CR34","doi-asserted-by":"publisher","unstructured":"Luck H (1965) Catalase. In: Bergmeyer HU (ed) Method of enzymatic analysis. Academic Press, New York, London, pp 885\u2013894. https:\/\/doi.org\/10.1016\/B978-0-12-395630-9.50158-4","DOI":"10.1016\/B978-0-12-395630-9.50158-4"},{"key":"967_CR35","first-page":"21","volume":"64","author":"RB Lydiard","year":"2003","unstructured":"Lydiard RB (2003) The role of GABA in anxiety disorders. J Clin Psychiatry 64:21\u201327","journal-title":"J Clin Psychiatry"},{"key":"967_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.07.180","author":"B Marples","year":"2012","unstructured":"Marples B, McGee MC, Martinez AA et al (2012) A new use for an old treatment: radiation therapy and Alzheimer\u2019s disease. Int J Radiat Oncol. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.07.180","journal-title":"Int J Radiat Oncol"},{"key":"967_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00252","author":"A Martorana","year":"2014","unstructured":"Martorana A, Koch G (2014) Is dopamine involved in Alzheimer\u2019s disease? Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2014.00252","journal-title":"Front Aging Neurosci"},{"key":"967_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01032-7","author":"T Maurice","year":"1996","unstructured":"Maurice T, Lockhart BP, Privat A (1996) Amnesia induced in mice by centrally administered \u03b2-amyloid peptides involves cholinergic dysfunction. Brain Res. https:\/\/doi.org\/10.1016\/0006-8993(95)01032-7","journal-title":"Brain Res"},{"key":"967_CR39","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.34.7.939","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of alzheimer\u2019s disease: report of the NINCDS-ADRDA work group\u22c6 under the auspices of department of health and human services task force on alzheimer\u2019s disease. Neurology. https:\/\/doi.org\/10.1212\/wnl.34.7.939","journal-title":"Neurology"},{"key":"967_CR40","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.2.784","author":"AT Monroe","year":"2004","unstructured":"Monroe AT, Walia R, Zlotecki RA, Jantz MA (2004) Tracheobronchial amyloidosis: a case report of successful treatment with external beam radiation therapy. Chest. https:\/\/doi.org\/10.1378\/chest.125.2.784","journal-title":"Chest"},{"key":"967_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(84)90007-4","author":"R Morris","year":"1984","unstructured":"Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. https:\/\/doi.org\/10.1016\/0165-0270(84)90007-4","journal-title":"J Neurosci Methods"},{"key":"967_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","volume":"25","author":"A Mudher","year":"2002","unstructured":"Mudher A, Lovestone S (2002) Alzheimer\u2019s disease: do tauists and baptists finally shake hands? Trends Neurosci 25:22\u201326","journal-title":"Trends Neurosci"},{"key":"967_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2013.10.014","author":"MA Mukhamedyarov","year":"2014","unstructured":"Mukhamedyarov MA, Volkov EM, Khaliullina DF et al (2014) Impaired electro-genesis in skeletal muscle fibers of transgenic Alzheimer mice. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2013.10.014","journal-title":"Neurochem Int"},{"key":"967_CR44","first-page":"133","volume":"37","author":"CB Nemeroff","year":"2003","unstructured":"Nemeroff CB (2003) The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 37:133\u2013146","journal-title":"Psychopharmacol Bull"},{"key":"967_CR45","volume-title":"Histochemistry, theoretical and applied","author":"AGE Pearse","year":"1968","unstructured":"Pearse AGE (1968) Histochemistry, theoretical and applied, 3rd edn. Churchill, London","edition":"3"},{"key":"967_CR46","first-page":"42","volume":"10","author":"S Poovaneswaran","year":"2008","unstructured":"Poovaneswaran S, Razak ARA, Lockman H et al (2008) Tracheobronchial amyloidosis: utilization of radiotherapy as a treatment modality. MedGenMed Medscape Gen Med 10:42","journal-title":"MedGenMed Medscape Gen Med"},{"key":"967_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-016-0188-8","author":"M Prince","year":"2016","unstructured":"Prince M, Ali GC, Guerchet M et al (2016) Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/s13195-016-0188-8","journal-title":"Alzheimers Res Ther"},{"key":"967_CR48","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3122\/jabfm.2012.03.100183","volume":"25","author":"CH Sadowsky","year":"2012","unstructured":"Sadowsky CH, Galvin JE (2012) Guidelines for the management of cognitive and behavioral problems in dementia. J Am Board Fam Med 25:350\u2013366","journal-title":"J Am Board Fam Med"},{"key":"967_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3233\/JAD-132483","volume":"40","author":"S Saharan","year":"2014","unstructured":"Saharan S, Mandal PK (2014) The emerging role of glutathione in alzheimer\u2019s disease. J Alzheimers Dis 40:519\u2013529","journal-title":"J Alzheimers Dis"},{"key":"967_CR50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.69031177.x","author":"G Sberna","year":"1997","unstructured":"Sberna G, S\u00e1ez-Valero J, Beyreuther K et al (1997) The amyloid \u03b2-protein of Alzheimer\u2019s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J Neurochem. https:\/\/doi.org\/10.1046\/j.1471-4159.1997.69031177.x","journal-title":"J Neurochem"},{"key":"967_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-017-0279-1","volume":"9","author":"S Schedin-Weiss","year":"2017","unstructured":"Schedin-Weiss S, Inoue M, Hromadkova L et al (2017) Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with \u03b3-secretase and regulates neuronal amyloid \u03b2-peptide levels. Alzheimers Res Ther 9:1\u201319","journal-title":"Alzheimers Res Ther"},{"key":"967_CR52","doi-asserted-by":"crossref","unstructured":"Selkoe DJ (2008) Soluble oligomers of the amyloid \u03b2-protein impair synaptic plasticity and behavior. Behav Brain Res","DOI":"10.1016\/j.bbr.2008.02.016"},{"key":"967_CR53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.7.2452","author":"TA Slotkin","year":"1990","unstructured":"Slotkin TA, Seidler FJ, Crain BJ et al (1990) Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.87.7.2452","journal-title":"Proc Natl Acad Sci USA"},{"key":"967_CR54","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell 120:545\u2013555","journal-title":"Cell"},{"key":"967_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2007.04.056","author":"L Trabace","year":"2007","unstructured":"Trabace L, Kendrick KM, Castrignan\u00f2 S et al (2007) Soluble amyloid beta1\u201342 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.04.056","journal-title":"Neuroscience"},{"key":"967_CR56","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021761310435","author":"VV Trubetskaya","year":"2003","unstructured":"Trubetskaya VV, Stepanichev MY, Onufriev MV et al (2003) Administration of aggregated beta-amyloid peptide (25\u201335) induces changes in long-term potentiation in the hippocampus in vivo. Neurosci Behav Physiol. https:\/\/doi.org\/10.1023\/A:1021761310435","journal-title":"Neurosci Behav Physiol"},{"key":"967_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.44","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. https:\/\/doi.org\/10.1038\/nprot.2007.44","journal-title":"Nat Protoc"},{"key":"967_CR58","doi-asserted-by":"publisher","DOI":"10.1042\/bj0990667","author":"ED Wills","year":"1966","unstructured":"Wills ED (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochem J. https:\/\/doi.org\/10.1042\/bj0990667","journal-title":"Biochem J"},{"issue":"5","key":"967_CR59","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1667\/RR14367.1","volume":"185","author":"GD Wilson","year":"2016","unstructured":"Wilson GD, Marples B (2016) A new use for an old treatment: radiation therapy and Alzheimer\u2019s disease. Radiat Res\u00a0185(5):443\u2013448.\u00a0https:\/\/doi.org\/10.1667\/RR14367.1","journal-title":"Radiat Res"},{"key":"967_CR60","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2147\/NDT.S7460","volume":"6","author":"W Xia","year":"2010","unstructured":"Xia W (2010) Brain amyloid \u03b2 protein and memory disruption in Alzheimer\u2019s disease. Neuropsychiatr Dis Treat\u00a06:605\u2013611.\u00a0https:\/\/doi.org\/10.2147\/NDT.S7460","journal-title":"Neuropsychiatr Dis Treat"},{"key":"967_CR61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0163-7258(00)00081-4","volume":"88","author":"K Yamada","year":"2000","unstructured":"Yamada K, Nabeshima T (2000) Animal models of Alzheimer\u2019s disease and evaluation of anti-dementia drugs. Pharmacol Ther 88:93\u2013113","journal-title":"Pharmacol Ther"},{"key":"967_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(19)81724-6","author":"WL Zahler","year":"1968","unstructured":"Zahler WL, Cleland WW (1968) A specific and sensitive assay for disulfides. J Biol Chem. https:\/\/doi.org\/10.1016\/s0021-9258(19)81724-6","journal-title":"J Biol Chem"},{"key":"967_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.09.017","author":"X Zang","year":"2018","unstructured":"Zang X, Cheng ZY, Sun Y et al (2018) The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on A\u03b21\u201342-induced cognitive impairment. Prog Neuropsychopharmacol Biol Psychiatry. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.09.017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Radiation and Environmental Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-022-00967-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00411-022-00967-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-022-00967-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T15:11:29Z","timestamp":1650467489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00411-022-00967-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1007\/s00411-022-00967-5","relation":{},"ISSN":["0301-634X","1432-2099"],"issn-type":[{"value":"0301-634X","type":"print"},{"value":"1432-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}